1. Academic Validation
  2. A tumor necrosis factor-alpha-inducible promoter variant of interferon-gamma accelerates CD4+ T cell depletion in human immunodeficiency virus-1-infected individuals

A tumor necrosis factor-alpha-inducible promoter variant of interferon-gamma accelerates CD4+ T cell depletion in human immunodeficiency virus-1-infected individuals

  • J Infect Dis. 2003 Jul 15;188(2):228-31. doi: 10.1086/376455.
Ping An 1 David Vlahov Joseph B Margolick John Phair Thomas R O'Brien James Lautenberger Stephen J O'Brien Cheryl A Winkler
Affiliations

Affiliation

  • 1 Basic Research Program, SAIC-Frederick, Inc., National Cancer Institute, Frederick, MD 21702, USA.
Abstract

A polymorphism, -179G/T, in the promoter of the interferon (IFN)-gamma gene (IFNG) confers differential tumor necrosis factor-alpha (TNF-alpha) inducibility to the IFNG promoter. The rarer allele, -179T, but not -179G, is inducible by TNF-alpha. We investigated the effects of IFNG -179G/T on AIDS pathogenesis. In 298 African American human immunodeficiency virus (HIV)-1 seroconverters, the IFNG -179G/T genotype was associated with accelerated progression to CD4 <200 and AIDS-1993, a finding suggesting that IFNG -179T is a risk factor for AIDS progression, as measured by CD4 cell count. It is possible that increased IFN-gamma production induced by TNF-alpha when -179T is present causes CD4 cell depletion by Apoptosis.

Figures